Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA.

Teresa Valdés-DelgadoAlicia Aguado-ParedesVicente Merino-BohórquezJesús Martín-ManzanaresMaría Mercedes AlonsoBelén MaldonadoLuisa CastroMaría BelvisBeatriz BenítezÁngel CaunedoMiguel Ángel CallejaFederico Argüelles-Arias

Published in: Digestive diseases and sciences (2023)

POC assay results in blood samples from patients with IBD were comparable to those obtained with the reference ELISA technique. The POC assay could be considered for routine testing based on its ease of use and rapidity.

Keyphrases

patients with inflammatory bowel disease
high throughput
ulcerative colitis
monoclonal antibody
clinical practice
single cell
sensitive detection